Is it time to say “goodbye” to tuberculin skin testing (TST) when on-boarding healthcare workers?

Healthcare personnel are at increased risk of tuberculosis (TB) infection. In this webinar, join L. Masae Kawamura, vice chair of vital strategies board and tuberculosis consultant at QIAGEN, as she provides an overview of screening healthcare professionals for TB infection. Kawamura will discuss the risks associated with TB infection and latent TB reactivation in the occupational health setting and describe current testing guidelines.

Kawamura will also explore the operational and medical differences between tuberculin skin test (TST) and modern TB blood tests (IGRAs).

Key learning objectives

• Understand the operational differences between TST and IGRAs
• Learn more about the medical difference between TST and IGRAs
• Find out more about the current policy recommendations for TST and IGRA use with health care workers (HCWs)

Who should attend?

• Health care workers
• Clinicians, physicians, and nurses
• Employee health directors
• Infectious disease specialists
• Lab directors
• Medical directors

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.